Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exploratory Study to Evaluate the Safety and Efficacy of CD5789 in Subjects with Early Stage Cutaneous T-Cell Lymphoma

Trial Profile

Exploratory Study to Evaluate the Safety and Efficacy of CD5789 in Subjects with Early Stage Cutaneous T-Cell Lymphoma

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Apr 2016

At a glance

  • Drugs Trifarotene (Primary)
  • Indications Cutaneous T-cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Mar 2015 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center record.
    • 13 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top